Complications and prognosis of cardiovascular compromise in patients with COVID-19: an integrative literature review
Complicações e prognóstico do comprometimento cardiovascular em pacientes com COVID-19: uma revisão integrativa da literatura
DOI:
https://doi.org/10.53660/CLM-1747-23M06Palavras-chave:
COVID-19, Cardiovascular system, Risk factors, Comorbidities, Cardiovascular diseasesResumo
This study aims to learn about the cardiovascular complications of COVID-19 and the clinical, laboratory and imaging predictors of myocardial injury and dysfunction resulting from SARS-CoV-2 infection, with a view to developing a plan of measures to reduce the risk of death from COVID-19 in people with cardiovascular disease. This is an integrative literature review carried out in electronic databases: PubMed, LILACS, Embase, Scopus, WOS and CINAHL, with the descriptors: Cardiovascular system; risk factors; Comorbidity; Cardiovascular diseases; Heart injury and Covid-19 with the inclusion of original studies in the period 2019-2022. The search resulted in 44 articles, in English, which highlighted the risk factors and/or comorbidities associated with cardiovascular complications potentiated by COVID-19; prognosis and increased mortality from cardiovascular causes induced by COVID-19. It is concluded that cardiovascular impairment can determine the severity and contribute to death in individuals with COVID-19, potentiated by pre-existing cardiovascular disease or cardiometabolic risk factors, affecting the need for ventilatory and hemodynamic support.
Downloads
Referências
AGHAJANI, M. H. et al. Is cardiac Troponin I Considered as A Predictor of In-hospital Mortality among COVID-19 Patients? A Retrospective Cohort Study. Bulletin of Emergency & Trauma, v. 10, n. 1, p. 9, 2022. doi: 10.30476/BEAT.2022.92719.1310
ARENTZ, M.; YIM, E.; KLAFF, L.; LOKDANDWALA, L. Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State. Jama, v. 323, n. 16, p. 1612-1614, 2020. doi: 10.1001/jama.2020.4326
BRASIL. Ministério da Saúde. Covid-19. Painel Coronavírus. Brasília: Ministério da Saúde, 2022. Disponível em: http://covid.saúde.gov.br/. Acesso em: 12 dez. 2022.
CAPAK, K. et al. Prevalence of somatic comorbidities among coronavirus disease 2019 patients in Croatia in the first pandemic wave: data from national public health databases. Croatian medical journal, v. 61, n. 6, p. 518, 2020. DOI: 10.3325/cmj.2020.61.518
CASE, B. C. et al. Clinical impact, and predictors of troponin elevation in patients with COVID-19. Cardiovascular Revascularization Medicine, v. 33, p. 41-44, 2021. DOI: 10.1016/j.carrev.2021.03.002
CHANGAL, K. et al. Myocardial injury in hospitalized COVID-19 patients: a retrospective study, systematic review, and meta-analysis. BMC Cardiovascular Disorders, v. 21, n. 1, p. 1-10, 2021. https://bmccardiovascdisord.biomedcentral.com/articles/10.1186/s12872-021-02450-3
CHEN, G. et al. Hypertension as a sequela in patients of SARS- Cov-2 infection. Plos One, v. 16, n. 4, p. e0250815, 2021. https://doi.org/10.1371/journal.pone.0250815
CHEN, X. et al. Coagulopathy is a major extrapulmonary risk factor for mortality in hospitalized patients with COVID-19 with type 2 diabetes. BMJ Open Diabetes Research and Care, v. 8, n. 2, p. e001851, 2020. DOI: 10.1136/bmjdrc-2020-001851
CIPRIANI, A. et al. Cardiac injury and mortality in patients with Coronavirus disease 2019 (COVID-19): insights from a mediation analysis. Internal and emergency medicine, v. 16, n. 2, p. 419-427, 2021. DOI: 10.1007/s11739-020-02495-w
DEMIR, O. M. et al. Impact and determinants of high-sensitivity cardiac troponin-T concentration in patients with COVID-19 admitted to critical care. The American Journal of Cardiology, v. 147, p. 129-136, 2021. DOI: 10.1016/j.amjcard.2021.01.037
DENG, P.; et al. The diagnostic and prognostic role of myocardial injury biomarkers in hospitalized patients with COVID-19. Clinica Chimica Acta, v. 510, p. 186-190, 2020. doi: 10.1016/j.cca.2020.07.018
FERRANDO, C.; et al. Patient characteristics, clinical course and factors associated to ICU mortality in critically ill patients infected with SARS-CoV-2 in Spain: A prospective, cohort, multicentre study. Revista Española de Anestesiologia y Reanimación (English Edition), v. 67, n. 8, p. 425-437, 2020. doi: 10.1016/j.redar.2020.07.003
GAO, Q. et al. The epidemiological characteristics of 2019 novel coronavirus diseases (COVID-19) in Jingmen, Hubei, China. Medicine (Baltimore), v. 99, n. 23, 2020. doi: 10.1097/MD.0000000000020605
GOMES, B. F. O. et al. Impact of High Cardiovascular Risk on Hospital Mortality in Intensive Care Patients Hospitalized for COVID-19. Arquivos Brasileiros de Cardiologia, v. 118, p. 927-934, 2022. https://doi.org/10.36660/abc.20210349
GRASSELLI, G. et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA, v. 323, n. 16, p. 1574-1581, 2020. doi:10.1001/jama.2020.5394
GRILLET, F. et al. Acute pulmonary embolism associated with COVID-19 pneumonia detected with pulmonary CT angiography. Radiology, v. 296, n. 3, p. E186-E188, 2020. https://doi.org/10.1148/radiol.2020201544
GUNAWARDENE, M.A.; et al. Prognostic Impact of Acute Cardiovascular Events in COVID-19 Hospitalized Patients—Results from the CORONA Germany Study. Journal of Clinical Medicine, v. 10, n. 17, p. 3982, 2021. https://bestpractice.bmj.com/topics/en-gb/3000201?utm_source=google&utm_medium=search&utm_campaign=usage&utm_term=covid&utm_content=comorbidities_campaign&gclid=CjwKCAjwtuOlBhBREiwA7agf1msntVdKm09MWJA1alHA90RCDjfLK1adsNY-gHX_8IKd6So2e8V7hxoCr8sQAvD_BwE
GUO, T.; et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID- 19). JAMA Cardiology, v. 5, n. 7, p. 811-818, 2020. doi: 10.1001/jamacardio.2020.1017
HAN, H.; et al. Analysis of heart injury laboratory parameters in 273 COVID‐19 patients in one hospital in Wuhan, China. Journal of Medical Virology, v. 92, n. 7, p. 819-823, 2020. DOI: 10.1002/jmv.25809
HANSON, P. J. et al. Characterization of COVID-19-associated cardiac injury: evidence for a multifactorial disease in an autopsy cohort. Laboratory Investigation, v. 102, n. 8, p. 814-825, 2022. https://www.nature.com/articles/s41374-022-00783-x
HE, J. et al. The prognostic value of myocardial injury in COVID‐19 patients and associated characteristics. Immunity, Inflammation and Disease, v. 9, n. 4, p. 1358-1369, 2021. doi: 10.1002/iid3.484
HE, X. et al.. Factors associated with acute cardiac injury and their effects on mortality in patients with COVID-19. Scientific reports, v. 10, n. 1, p. 1-9, 2020. https://doi.org/10.1038/s41598-020-77172-1
HE, Y. et al. Key factors leading to fatal outcomes in COVID-19 patients with cardiac injury. Scientific Reports, v. 11, n. 1, p. 1-7, 2021. ttps://doi.org/10.1038/s41598-021-82396-w
HUANG, C.; et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet, v. 395, n. 10223, p. 497-506, 2020. doi: 10.1016/S0140-6736(20)30183-5
KARAHAN, S. et al. Impact of acute myocardial injury on prognosis in patients with COVID-19. European Review for Medical and Pharmacological Sciences, v. 25, n. 5, p. 2425-2434, 2021. DOI: 10.26355/eurrev_202103_25284
LALA, A. et al. Prevalence and impact of myocardial injury in patients hospitalized with COVID-19 infection. Journal of the American College of Cardiology, v. 76, n. 5, p. 533-548, 2020. DOI: 10.1016/j.jacc.2020.06.007
LI, C.; et al. Longitudinal correlation of biomarkers of cardiac injury, inflammation, and coagulation to outcome in hospitalized COVID-19 patients. Journal of Molecular and Cellular Cardiology, v. 147, p. 74-87, 2020. DOI: 10.1016/j.yjmcc.2020.08.008
LI, X. et al. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. Journal of Allergy and Clinical Immunology, v. 146, n. 1, p. 110-118, 2020. DOI: 10.1016/j.jaci.2020.04.006
LI, Y. et al. Echocardiographic characteristics, and outcome in patients with COVID- 19 infection and underlying cardiovascular disease. Frontiers in Cardiovascular Medicine, v. 8, p. 642973, 2021. https://doi.org/10.3389/fcvm.2021.642973
LI, Y.; HU, Y.; YU, J.; MA, T. Retrospective analysis of laboratory testing in 54 patients with severe-or critical-type 2019 novel coronavirus pneumonia. Laboratory investigation, v. 100, n. 6, p. 794-800, 2020. doi: 10.1038/s41374-020-0431-6
LIBERATI, A. et al. The PRISMA Statement for Reporting Systematic Reviews and MetaAnalyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration. Annals of internal medicine, v. 151, n. 4, p.W-65-W94, 2009. DOI: 10.1371/journal.pmed.1000100
LOMBARDI, C. M. et al. Association of troponin levels with mortality in Italian patients hospitalized with coronavirus disease 2019. JAMA Cardiology, v. 5, n. 11, p. 1274-1280, 2020. DOI: 10.1001/jamacardio.2020.3538
LU, J.Q. et al. Clinical predictors of acute cardiac injury and normalization of troponin after hospital discharge from COVID-19. EBioMedicine, v. 76, p. 103821, 2022. DOI: 10.1016/j.ebiom.2022.103821
NAEEM, K. B. et al. Acute cardiac injury is associated with adverse outcomes, including mortality in COVID-19 patients, Saudi Med J, v. 41, n. 11, p. 1204–1210, 2020. doi: 10.15537/smj.2020.11.25466
NASCIMENTO, J. H. et al. COVID-19 and myocardial injury in a Brazilian ICU: High incidence and higher risk of in-hospital mortality. Arquivos Brasileiros de Cardiologia, v. 116, p. 275-282, 2021. DOI: 10.36660/abc.20200671
NISHIGA, M. et al. Covid-19 and cardiovascular disease: from basic mechanisms to clinical perspectives. Nature Reviews Cardiology, v. 17, n. 9, p. 543-558, 2020. https://doi.org/10.1038/s41569-020-0413-9
ORGANIZAÇÃO MUNDIAL DA SAÚDE (OMS). Folha informativa: Doenças Cardiovasculares [Internet]. Brasília: OPAS Brasil; 2020. Disponível em: https://www.paho.org/bra/index.php?option=comcontente&view=article&id=6101:covid19&Itemid=875. Acesso em: 03 ago. 2020.
PUNTMANN, V. O. et al. Long-term cardiac pathology in individuals with mild initial COVID-19 illness. Nature Medicine, v. 28, n. 10, p. 2117-2123, 2022. https://www.nature.com/articles/s41591-022-02000-0
PUNTMANN, V. O. et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA cardiology, v. 5, n. 11, p. 1265-1273, 2020. doi:10.1001/jamacardio.2020.3557
RAAFS, A. G. et al. Cardiovascular outcome 6 months after severecoronavirus disease 2019 infection. Journal of Hypertension, v. 40, n. 7, p. 1278-1287, 2022. DOI: 10.1097/HJH.0000000000003110
RICHARDSON, S. et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA, v. 323, n. 20, p. 2052-2059, 2020. doi: 10.1001/jama.2020.6775.
RUAN, Q. et al. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Medicine, v. 46, n.5, p. 846-848, 2020. DOI: 10.1007/s00134-020-05991-x
SANTOS, C. M. C.; PIMENTA, C. A M.; NOBRE, M. R. C. A estratégia PICO para a construção da pergunta de pesquisa e busca de evidências. Revista Latino- americana de Enfermagem, v. 15, n. 3, p. 508-511, 2007. https://doi.org/10.1590/S0104-11692007000300023
SI, D. et al. Death, discharge, and arrhythmias among patients with COVID-19 and cardiac injury. Cmaj, v. 192, n. 28, p. E791-E798, 2020. DOI: 10.1503/cmaj.200879
SOUZA, M.T; DIAS, M; CARVALHO, R. Revisão Integrativa: o que é e como fazer. Einstein (São Paulo), v. 8, n. 1, p. 102-106, 2010. https://www.scielo.br/j/eins/a/ZQTBkVJZqcWrTT34cXLjtBx/?format=pdf&lang=pt
TEIXEIRA, E. et al. Revisão integrativa da literatura passo-a-passo & convergências com outros métodos de revisão. Revista de Enfermagem da UFPI, Teresina, v. 2, n. 5 (esp.), p. 3-7, dez. 2013. Disponível em: https://revistas.ufpi.br/index.php/reufpi/article/view/1457. Acesso em: 03 ago. 2020.
THAPA, S. B. et al. Clinical outcomes of in-hospital cardiac arrest in COVID-19. JAMA Internal Medicine, v. 181, n. 2, p. 279-281, 2021. doi: 10.1001/jamainternmed.2020.4796
TIAN, S. et al. Characteristics of COVID-19 infection in Beijing. Journal of infection, v. 80, n. 4, p. 401-406, 2020. DOI: 10.1016/j.jinf.2020.02.018
TIAN, W. et al. Predictors of mortality in hospitalized COVID-19 patients: a systematic review and meta-analysis. Journal of Medical Virology, v. 92, n. 10, p. 1875-1883, 2020. DOI: 10.1002/jmv.26050
VILLAVICENCIO, C. et al. Myocardial injury as a prognostic factor in critically ill patients with severe SARS-CoV-2 pneumonia. Medicina Intensiva, v. 47, n. 1, p. 48-51, 2023. doi: 10.1016/j.medin.2022.05.003.
WANG, D. et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA, v. 323, n. 11, p. 1061-1069, 2020. doi: 10.1001/jama.2020.1585
WANG, Q. et al. Clinical value of laboratory indicators for predicting disease progression and death in patients with COVID-19: a retrospective cohort study. BMJ open, v. 11, n. 10, p. e043790, 2021. https://bmjopen.bmj.com/content/11/10/e043790
WEBER, B. et al. Relationship Between Myocardial Injury During Index Hospitalization for SARS‐CoV‐2 Infection and Longer‐Term Outcomes. Journal of the American Heart Association, v. 11, n. 1, p. e022010, 2022. https://doi.org/10.1161/JAHA.121.022010
WORLD HEALTH ORGANIZATION (WHO). Coronavírus disease (COVID -19): situation dashboard. Genebra, 2022. Disponível em: https://experience arcgis.com/experience/685d0ace521648f8a5beeeee1b9125cd. Acesso em: 12 dez. 2022.
WU, Z.; MCGOOGAN, J. M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA, v. 323, n. 13, p. 1239-1242, 2020. doi:10.1001/jama.2020.2648
XIONG, S. et al. Clinical characteristics of 116 hospitalized patients with COVID-19 in Wuhan, China: a single-centered, retrospective, observational study. BMC infectious diseases, v. 20, n. 1, p. 1-11, 2020. https://doi.org/10.1186/s12879-020-05452-2
YANG, C.; JIN, Z. An acute respiratory infection runs into the most common noncommunicable Epidemic-COVID-19 and cardiovascular diseases. JAMA Cardiology, v. 5, n. 7, p. 743-744, 2020. DOI: 10.1001/jamacardio.2020.0934
YANG, P. et al. Admission fasting plasma glucose is an independent risk factor for 28‐ day mortality in patients with COVID‐19. Journal of Medical Virology, v. 93, n. 4, p. 2168-2176, 2021. DOI: 10.1002/jmv.26608
YANG, X. et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. The Lancet Respiratory Medicine, v. 8, n. 5, p. 475-481, 2020. DOI: 10.1016/S2213-2600(20)30079-5
ZHOHGHUA, L.; XING, B.; ZHI, Z. The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China, v. 41, n. 2, p. 145-151, 2019. DOI: 10.3760/cma.j.issn.0254-6450.2020.02.003
ZHOU, F. et al. Clinical course, and risk factors for mortality of adult in patients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet, v. 395, n. 10229, p. 1054-1062, 2020. DOI:https://doi.org/10.1016/S0140-6736(20)30566-3
